1-6 of 6
A. M. Carella, MD
Close
Sort by
Journal Articles

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Carlo Marani, MD, Raffaella Grasso, PhD, Nicoletta Colombo, Marino Clavio, MD, Fabio Guolo, MD, Annalisa Kunkl, Livia Giannoni, MD, Giuseppina Fugazza, PhD, Roberto Bruzzone, Mario Sessarego, MD, A. M. Carella, MD, Marco Gobbi, MD, Maurizio Miglino, PhD
Journal: Blood
Blood (2012) 120 (21): 2535.
https://doi.org/10.1182/blood.V120.21.2535.2535
Published: 2012
Journal Articles

Clarithromycin Enhances tyrosine Kinase Inhibitor – Induced Cell Death by Inhibition of Late Stage Autophagy in Patients with Chronic Myeloid Leukemia At Diagnosis or with Resistant Stage of Disease

A. M. Carella, MD, G. Beltrami, MD, G. Pica, MD, C. Ghiggi, MD, D. Lovera, MD, G. Cirmena, A. Garuti
Journal: Blood
Blood (2012) 120 (21): 3777.
https://doi.org/10.1182/blood.V120.21.3777.3777
Published: 2012
Journal Articles

Safety and Efficacy of 90Y Ibritumomab Tiuxetan (Zevalin®) for Untreated FollicularNon-Hodgkin's Lymphoma (FL) Patients, An Italian Cooperative Study

G. Pica, S. Nati, Umberto Vitolo, MD, Sara Galimberti, Pier Luigi Zinzani, MD, PhD, Nicola Cascavilla, Mario Petrini, MD, A. M. Carella, MD
Journal: Blood
Blood (2011) 118 (21): 100.
https://doi.org/10.1182/blood.V118.21.100.100
Published: 2011
Journal Articles

Clarithromycin Targeting Autophagy Potentiates Tyrosine Kinase Inhibitor-Induced Cell Death in Resistant Chronic Myeloid Leukemia (CML) Patients

A. M. Carella, MD, Gioacchino Catania, MD, G. Beltrami, G. Pica
Journal: Blood
Blood (2011) 118 (21): 4450.
https://doi.org/10.1182/blood.V118.21.4450.4450
Published: 2011
Journal Articles

GeneXpert Essay for BCR-ABL Compared to RT-PCR for Clinical Management of CML

G. Pica, G. Catania, F. Castelli, C Repetto, A. M. Carella, MD, M. Mussap
Journal: Blood
Blood (2011) 118 (21): 4416.
https://doi.org/10.1182/blood.V118.21.4416.4416
Published: 2011
Journal Articles

A Phase I Study of Hypofractionated Tailored Total Marrow or Total Lymphoid Irradiation with Helical Tomotherapy Plus Chemotherapy As a Conditioning Regimen for Autologous Stem Cell Transplantation

G. Pica, S. Vagge, G. Beltrami, S. Nati, G. Catania, R. Corvò, A. M. Carella, MD
Journal: Blood
Blood (2011) 118 (21): 4523.
https://doi.org/10.1182/blood.V118.21.4523.4523
Published: 2011